4//SEC Filing
Celldex Therapeutics, Inc. 4
Accession 0001179110-17-009155
$CLDXCIK 0000744218operating
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 9:27 AM ET
Size
5.7 KB
Accession
0001179110-17-009155
Insider Transaction Report
Form 4
Davis Thomas Andrew
Sr. VP & CMO
Transactions
- Award
Incentive Stock Option (right to buy)
2017-06-15+150,000→ 150,000 totalExercise: $2.32From: 2018-06-15Exp: 2027-06-15→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.
- [F2]25% vest on June 15, 2018 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000744218
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 9:27 AM ET
- Size
- 5.7 KB